Medifast (MED) Finished Goods (2011 - 2021)

Medifast has reported Finished Goods for 9 years, with the latest figure at $100.7 million in Q3 2021.

• For the quarter ending Q3 2021, Finished Goods rose 387.59% year-over-year to $100.7 million; the trailing twelve-month figure through Sep 2021 stood at $100.7 million (up 387.59% YoY), and the FY2020 full-year result was $29.9 million, down 4.65% from the prior year.
• Finished Goods for Q3 2021 stood at $100.7 million, up from $73.1 million in the prior quarter.
• The five-year high for Finished Goods was $100.7 million in Q3 2021, with the low at $10.5 million in Q3 2017.
• Historically, Finished Goods has averaged $30.3 million across 5 years, with a median of $27.5 million in 2018.
• Annual changes were most pronounced in 2020 — Finished Goods slumped 38.84% — and 2021, when it jumped 387.59%.
• Medifast's Finished Goods stood at $13.4 million in 2017, then jumped by 90.27% to $25.5 million in 2018, then increased by 22.76% to $31.3 million in 2019, then dropped by 4.65% to $29.9 million in 2020, then jumped by 237.22% to $100.7 million in 2021.
• The last three Finished Goods figures came in at $100.7 million (Q3 2021), $73.1 million (Q2 2021), and $40.5 million (Q1 2021), per Business Quant data.